leucine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askow, AT; Beaudry, KM; Burd, NA; De Lisio, M; Hamann, JS; Li, Z; McKenna, CF; Paluska, SA; Paulussen, KJM; Salvador, AF; Scaroni, SE; Ulanov, AV | 1 |
| Arsenijević, N; Cvijović, M; Kaluderović, GN; Milovanović, M; Sabo, TJ; Trifunović, SR; Volarević, V; Vujić, JM; Zmejkovski, BB | 1 |
| Ansorge, S; Faust, J; Frank, K; Kähne, T; Lendeckel, U; Neubert, K; Reinhold, D; Wex, T | 1 |
| Koski, T; Vilpo, JA; Vilpo, LM | 1 |
| Horikoshi, A; Hosokawa, Y; Irie, T; Ishizuka, H; Ohkubo, T; Sawada, S | 1 |
1 trial(s) available for leucine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Creatine Monohydrate Supplementation, but not Creatyl-L-Leucine, Increased Muscle Creatine Content in Healthy Young Adults: A Double-Blind Randomized Controlled Trial.
Topics: Amides; Body Composition; Creatine; Dietary Supplements; Double-Blind Method; Female; Humans; Leucine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Muscle Strength; Muscle, Skeletal; Young Adult | 2022 |
4 other study(ies) available for leucine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Palladium(II) complexes with R(2)edda derived ligands. Part IV. O,O'-dialkyl esters of (S,S)-ethylenediamine-N,N'-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: synthesis, characterization and in vitro antitumoral activi
Topics: Antineoplastic Agents; Cell Line, Tumor; Edetic Acid; Esters; Ethylenediamines; Humans; Inhibitory Concentration 50; Leucine; Leukemia, Lymphocytic, Chronic, B-Cell; Ligands; Organometallic Compounds; Palladium; Spectrum Analysis | 2010 |
Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.
Topics: CD13 Antigens; Cell Line; Cell Membrane; Cells, Cultured; DNA; Enzyme Induction; Enzyme Inhibitors; Humans; Hydroxamic Acids; Leucine; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Activation; Oligopeptides; Phytohemagglutinins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes; Tumor Cells, Cultured | 1996 |
Selective toxicity of vincristine against chronic lymphocytic leukemia cells in vitro.
Topics: Aged; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Cytoskeletal Proteins; DNA Fragmentation; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Female; Flow Cytometry; Humans; Leucine; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Male; Microscopy, Fluorescence; Middle Aged; Time Factors; Vincristine | 2000 |
Effect of ubenimex on a CD5-CD13+ CLL patient with an aggressive clinical course.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; CD13 Antigens; CD5 Antigens; Humans; Leucine; Leukemia, Lymphocytic, Chronic, B-Cell; Male | 2000 |